10-K Decoder · All companies

Xeris Biopharma Holdings, Inc.

XERS · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$292M$203M+43.7%
Operating income$24.9M−$33.6M
Net income$550K−$54.8M

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$107M$74.4M+44.1%
Operating income$16.9M$6.70M+152%
Net income$11.3M$600K+1,783%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Xeris's revenue in FY2025?
$292M in FY2025 (Fiscal year ended Dec 31, 2025), +43.7% vs $203M a year earlier, per its 10-K filed Mar 2026.
Was Xeris profitable in FY2025?
Yes: net income was $550K and operating income $24.9M in FY2025.
What was Xeris's revenue in Q3 2026?
$107M (+44.1% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.